Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Certolizumab pegol
Cimzia
Routinely available
SMC (SMC2132)
29/03/2023
Indication
Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy
Therapeutic Area
Skin
Status Description
Routinely available in line with national guidance
Formulation
200mg solution for injection in pre-filled syringe and pen
Comments
-